title: The effect of endurance exercise on both skeletal muscle and systemic oxidative stress in previously sedentary obese men.
abstract: BACKGROUND
  Obesity is associated with low-grade systemic inflammation, in part because of secretion of proinflammatory cytokines, resulting into peripheral insulin resistance (IR). Increased oxidative stress is proposed to link adiposity and chronic inflammation. The effects of endurance exercise in modulating these outcomes in insulin-resistant obese adults remain unclear. We investigated the effect of endurance exercise on markers of oxidative damage (4-hydroxy-2-nonenal (4-HNE), protein carbonyls (PCs)) and antioxidant enzymes (superoxide dismutase (SOD), catalase) in skeletal muscle; urinary markers of oxidative stress (8-hydroxy-2-deoxyguanosine (8-OHdG), 8-isoprostane); and plasma cytokines (C-reactive protein (CRP), interleukin-6 (IL-6), leptin, adiponectin).
  
  
  METHODS
  Age- and fitness-matched sedentary obese and lean men (n=9 per group) underwent 3 months of moderate-intensity endurance cycling training with a vastus lateralis biopsy, 24-h urine sample and venous blood samples taken before and after the intervention.
  
  
  RESULTS
  Obese subjects had increased levels of oxidative damage: 4-HNE (+37%; P0.03) and PC (+63%; P0.02); evidence of increased adaptive response to oxidative stress because of elevated levels of copper/zinc SOD (Cu/ZnSOD) protein content (+84%; P0.01); increased markers of inflammation: CRP (+737%; P0.0001) and IL-6 (+85%; P0.03), and these correlated with increased markers of obesity; and increased leptin (+262%; P0.0001) with lower adiponectin (-27%; P0.01) levels vs lean controls. Training reduced 4-HNE (-10%; P0.04), PC (-21%; P0.05), 8-isoprostane (-26%; P0.02) and leptin levels (-33%; P0.01); had a tendency to decrease IL-6 levels (-21%; P=0.07) and IR (-17%; P=0.10); and increased manganese SOD (MnSOD) levels (+47%; P0.01).
  
  
  CONCLUSIONS
  Endurance exercise reduced skeletal muscle-specific and systemic oxidative damage while improving IR and cytokine profile associated with obesity, independent of weight loss. Hence, exercise is a useful therapeutic modality to reduce risk factors associated with the pathogenesis of IR in obesity.
authors.affiliation: 1] Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada [2] Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
authors.forename: I A
authors.initials: IA
authors.lastname: Samjoo
authors.forename: A
authors.initials: A
authors.lastname: Safdar
authors.forename: M J
authors.initials: MJ
authors.lastname: Hamadeh
authors.forename: S
authors.initials: S
authors.lastname: Raha
authors.forename: M A
authors.initials: MA
authors.lastname: Tarnopolsky
references.citation: Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
references.pmid: 10092513
references.citation: Free Radic Biol Med. 2008 Jan 15;44(2):126-31
references.pmid: 18191748
references.citation: Eur J Appl Physiol. 2001 Jan-Feb;84(1-2):1-6
references.pmid: 11394236
references.citation: Nature. 2000 Nov 9;408(6809):239-47
references.pmid: 11089981
references.citation: Int J Obes Relat Metab Disord. 2001 Mar;25(3):378-88
references.pmid: 11319636
references.citation: Diabetes Obes Metab. 2007 Nov;9(6):813-39
references.pmid: 17924865
references.citation: Am J Physiol. 1994 Aug;267(2 Pt 2):R439-45
references.pmid: 8067452
references.citation: Circulation. 1983 May;67(5):968-77
references.pmid: 6219830
references.citation: J Clin Invest. 2004 Dec;114(12):1752-61
references.pmid: 15599400
references.citation: Am J Physiol Cell Physiol. 2001 Mar;280(3):C621-7
references.pmid: 11171582
references.citation: Physiol Genomics. 2008 Jan 17;32(2):219-28
references.pmid: 17957000
references.citation: Physiol Rev. 2009 Jan;89(1):27-71
references.pmid: 19126754
references.citation: FEBS Lett. 2003 Sep 11;551(1-3):104-6
references.pmid: 12965212
references.citation: Diabetes Care. 2004 Jul;27(7):1756-8
references.pmid: 15220262
references.citation: FASEB J. 2005 Sep;19(11):1498-500
references.pmid: 15985525
references.citation: Cancer Res. 1984 Oct;44(10):4224-32
references.pmid: 6380705
references.citation: Metabolism. 2007 Mar;56(3):332-8
references.pmid: 17292721
references.citation: Free Radic Biol Med. 2008 Aug 15;45(4):503-11
references.pmid: 18502211
references.citation: IUBMB Life. 2006 May-Jun;58(5-6):372-3
references.pmid: 16754333
references.citation: Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33
references.pmid: 21459257
references.citation: Am J Physiol Endocrinol Metab. 2013 Mar 1;304(5):E453-65
references.pmid: 23277185
references.citation: Mol Aspects Med. 2003 Aug-Oct;24(4-5):281-91
references.pmid: 12893006
references.citation: Biochim Biophys Acta. 1987 May 19;924(2):292-6
references.pmid: 3567220
references.citation: Nat Rev Endocrinol. 2012 Apr 03;8(8):457-65
references.pmid: 22473333
references.citation: Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1553-67
references.pmid: 16356119
references.citation: Free Radic Biol Med. 2005 Jul 15;39(2):289-95
references.pmid: 15964520
references.citation: Int J Obes (Lond). 2006 Jan;30(1):141-6
references.pmid: 16158088
references.citation: Diabetes. 2003 Jan;52(1):1-8
references.pmid: 12502486
references.citation: Diabetes Care. 1998 Oct;21(10):1736-42
references.pmid: 9773740
references.citation: Diabetes Care. 1999 May;22(5):818-22
references.pmid: 10332688
references.citation: Annu Rev Physiol. 1976;38:273-91
references.pmid: 130825
references.citation: Appl Physiol Nutr Metab. 2009 Feb;34(1):60-5
references.pmid: 19234586
references.citation: J Biol Chem. 1967 May 10;242(9):2278-82
references.pmid: 4290225
references.citation: Free Radic Biol Med. 2007 Mar 1;42(5):665-74
references.pmid: 17291990
references.citation: J Appl Physiol (1985). 2006 May;100(5):1657-65
references.pmid: 16357066
references.citation: Diabetes. 1999 Jan;48(1):1-9
references.pmid: 9892215
references.citation: Int J Obes Relat Metab Disord. 1994 Jan;18(1):25-33
references.pmid: 8130812
references.citation: Nature. 2006 Apr 13;440(7086):944-8
references.pmid: 16612386
references.citation: Exp Gerontol. 2009 Oct;44(10):625-33
references.pmid: 19622391
references.citation: Obesity (Silver Spring). 2008 Oct;16(10):2281-8
references.pmid: 18719669
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9
references.pmid: 11502817
references.citation: Am J Physiol. 1997 Jan;272(1 Pt 2):R363-9
references.pmid: 9039030
references.citation: Metabolism. 2004 Sep;53(9):1233-42
references.pmid: 15334390
references.citation: FEBS Lett. 1995 Jul 17;368(2):225-9
references.pmid: 7628610
references.citation: Am J Physiol. 1993 Mar;264(3 Pt 1):C715-22
references.pmid: 8460674
references.citation: J Appl Physiol (1985). 2008 Mar;104(3):708-15
references.pmid: 18079266
references.citation: J Am Coll Cardiol. 2000 Jun;35(7):1860-6
references.pmid: 10841236
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4135-40
references.pmid: 21368114
references.citation: J Anat. 2000 Nov;197 Pt 4:539-41
references.pmid: 11197526
references.citation: Nat Med. 2005 Feb;11(2):191-8
references.pmid: 15685170
references.citation: J Clin Invest. 2003 Dec;112(12):1796-808
references.pmid: 14679176
references.citation: Nat Rev Immunol. 2011 Aug 05;11(9):607-15
references.pmid: 21818123
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Life Sci. 2003 Feb 21;72(14):1627-33
references.pmid: 12551751